Cleo Diagnostics Ltd, a biotechnology company, engages in the development and patent of a blood test for the detection of ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia.
常見問題
Cleo Diagnostics 今天的股價是多少?▼
COV.AU 目前價格為 A$0.30 AUD,過去 24 小時下跌了 -1.67%。在圖表上更密切關注 Cleo Diagnostics 股票的表現。
Cleo Diagnostics 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 Australia Exchange 交易所,Cleo Diagnostics 的股票以代號 COV.AU 進行交易。
Cleo Diagnostics 的股價在上漲嗎?▼
COV.AU 股票較上週上漲 +0%,本月下跌 -14.49%,過去一年 Cleo Diagnostics 下跌 -28.05%。
Cleo Diagnostics 的市值是多少?▼
今天 Cleo Diagnostics 的市值為 40.45M
Cleo Diagnostics 去年的營收是多少?▼
Cleo Diagnostics 去年的營收為 0AUD。
Cleo Diagnostics 去年的淨利是多少?▼
COV.AU 去年的淨收益為 -5.94MAUD。
Cleo Diagnostics 位於哪個產業?▼
Cleo Diagnostics從事於Health & Wellness產業。
Cleo Diagnostics 何時完成拆股?▼
Cleo Diagnostics 最近沒有進行任何拆股。
Cleo Diagnostics 的總部在哪裡?▼
Cleo Diagnostics 的總部位於 澳洲 的 Melbourne。